Skip to main content
IOVA
NASDAQ Life Sciences

FDA Clears Iovance's Next-Gen TIL Therapy IOV-5001 for Solid Tumor Trials

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$4.03
Mkt Cap
$1.831B
52W Low
$1.66
52W High
$5.63
52W Position info
143% above low
Off High info
28% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

IOVA has more than doubled off its 52-week low of $1.66.

Summary

Iovance Biotherapeutics received FDA clearance for its Investigational New Drug (IND) application for IOV-5001, a next-generation IL-12 tethered TIL therapy. This allows the company to initiate Phase 1/2 trials in the second half of 2026 for various solid tumors, including advanced colorectal and breast cancers, representing a large patient population. The therapy is designed to enhance efficacy and safety by localizing IL-12 expression within the tumor. This development significantly expands Iovance's clinical pipeline beyond its existing FDA-approved Amtagvi therapy and could open new treatment frontiers for difficult-to-treat cancers.

At the time of this announcement, IOVA was trading at $4.03 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.8B. The 52-week trading range was $1.66 to $5.63. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

IOVA - Latest Insights

IOVA
Nov 05, 2026, 9:15 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $8.43
Real-time Price: $7.47 info
Change: -$0.9685 (-11%) info
Market Cap: $3.461B info
IOVA
Nov 05, 2026, 7:00 AM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $9.24
Real-time Price: $7.47 info
Change: -$1.78 (-19%) info
Market Cap: $3.461B info
IOVA
Oct 29, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $9.38
Real-time Price: $7.47 info
Change: -$1.91 (-20%) info
Market Cap: $3.461B info
IOVA
Oct 29, 2026, 3:11 PM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $9.69
Real-time Price: $7.47 info
Change: -$2.22 (-23%) info
Market Cap: $3.461B info
IOVA
Oct 29, 2026, 7:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $13.13
Real-time Price: $7.47 info
Change: -$5.67 (-43%) info
Market Cap: $3.461B info